News

FDA Fast Track Given to Valneva and LimmaTech's Shigella Vaccine

FDA Fast Track Given to Valneva and LimmaTech's Shigella Vaccine

Valneva and LimmaTech Secure FDA Fast Track Designation

Valneva SE (NASDAQ: VALN; Euronext Paris: VLA), a leader in specialty vaccines, and LimmaTech Biologics AG, a developer of vital biotech solutions, celebrate a significant milestone. They announced that their tetravalent bioconjugate Shigella vaccine candidate S4V has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). This designation accelerates the process for critical products aiming to address serious health conditions and unmet medical needs.

Understanding Fast Track Designation

Fast Track designation is a crucial FDA initiative aimed at facilitating the development of treatments for serious diseases and expedites the review of these essential new therapies. This program aims to streamline the pathway to getting vital treatments into the hands of those who need them most as quickly as possible.

CEO Insights

Thomas Lingelbach, the Chief Executive Officer of Valneva, highlighted the urgency of addressing shigellosis, a leading cause of fatal diarrhea globally, noting, "Currently, there is no approved Shigella vaccine. The Fast Track designation allows us to closely collaborate with the FDA to expedite our progress in developing remedies for this devastating disease."

Partnerships and Development Plans

The partnership between Valneva and LimmaTech includes an exclusive licensing agreement for the S4V candidate, further asserting their commitment to combat this health threat. Following favorable results from earlier clinical trials, Valneva is prepared to advance into Phase 2 studies that will investigate the vaccine's efficacy, especially among high-risk populations.

Shigellosis and its Global Impact

Shigellosis poses a significant public health challenge, particularly in low- and middle-income countries (LMICs) where it's estimated that there are about 165 million cases annually. This illness accounts for approximately 600,000 deaths each year, primarily affecting children under five years old. As international travel increases, the risk also extends to individuals from wealthier nations and military personnel deployed in endemic areas.

The Need for an Effective Vaccine

Despite the critical need, there are currently no licensed vaccines for Shigella, which complicates management and treatment. The standard approaches of oral rehydration and antibiotics face challenges due to rising antibiotic resistance, making the development of new preventive solutions imperative.

Future Directions

Valneva's S4V has a promising path ahead, leveraging a combination of Controlled Human Infection Model studies for initial approval in adults. The plan includes expanding indications for pediatric populations, thereby addressing a broader segment of the community affected by shigellosis. The targeted approach to development signals significant potential for comprehensive health solutions.

Company Profiles

Valneva SE is dedicated to the innovative development of vaccines, focusing on unmet needs for infectious diseases. Their extensive portfolio includes the world’s first and only chikungunya vaccine, among others. Their commitment to advancing significant health solutions is underscored by a strong R&D pipeline.

LimmaTech Biologics AG is recognized for its pioneering work in tackling the global antimicrobial resistance crisis. Their advanced vaccine technologies and strategic approaches aim to create impactful solutions for infectious diseases, revealing a commitment to global health.

Contact Information

Valneva Investor & Media Contacts
Laetitia Bachelot-Fontaine, VP Global Communications & European Investor Relations
M +33 (0)6 4516 7099
laetitia.bachelot-fontaine@valneva.com

Joshua Drumm, Ph.D., VP Global Investor Relations
M +001 917 815 4520
joshua.drumm@valneva.com

Media Enquiries
Trophic Communications
Gretchen Schweitzer or Alison Opalko
Phone: +49 172 861 8540
E-mail: limmatech@trophic.eu

Frequently Asked Questions

What is the significance of Fast Track designation?

Fast Track designation expedites the clinical development and review of treatments addressing serious diseases, aiming to deliver solutions to patients sooner.

Why is the S4V vaccine important for public health?

Shigellosis causes significant morbidity and mortality worldwide, especially among children. The S4V vaccine aims to fill the gap by providing preventive solutions.

What are the next steps for the S4V vaccine's development?

The S4V vaccine will undergo Phase 2 studies to evaluate its efficacy and expand its usage to children, enhancing public health measures against shigellosis.

How does Valneva contribute to vaccine innovation?

Valneva specializes in developing vaccines for infectious diseases that meet unmet medical needs, using innovative methodologies to advance their vaccine pipeline.

Who are the key players behind the S4V vaccine?

The S4V vaccine is a collaborative effort between Valneva SE and LimmaTech Biologics AG, focusing on innovative solutions for preventing shigellosis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 78

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 54

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 27

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 107

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 190

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 64

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 119

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
VIO Med Spa’s Black Friday Event: Aesthetic Savings

Updated Category News Views 152

Kicking Off the Holiday Season with a Glow Just when you think the holiday hustle can't get busier, VIO Med Spa is opening the gates of rejuvenation just in time to add yourself to that epic list. Starting November 16, VIO launches its Black Friday extravaganza—a deal-laden kick-off that means smooth skin and sharper looks are up for grabs. Member Benefits and Public...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 41

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Panasonic Showcases Rugged Tech at NATO Edge 26

Updated Category News Views 56

Panasonic Heads to Turkey with Tactical Tech Panasonic's got its sights set on proving a point at NATO Edge 26, busting out its TOUGHBOOK line and showing just how these rugged laptops aren't just tough, but also strategically essential. From November 17th through 19th, down in Turkey, these devices are taking the spotlight as they embrace the operational challenges of...

Continue Reading

Top 5 Most Recently Viewed Articles

Legacy of Lovers Unveils Transformative Single Addition

Updated Category News Views 154

Legacy of Lovers Launches New Musical Journey with 'Calm Cool Connection' With an exciting new release, Endless Love embraces the future of music with their single 'Calm Cool Connection'. This dynamic piece captures the essence of personal transformation and encourages listeners to embrace their own journeys. The track stands out, infused with bright melodies and...

Continue Reading
Major Shareholding Update for Park Street A/S Shareholders

Updated Category News Views 162

Significant Shareholding Announcement Park Street A/S is making headlines with its recent announcement regarding major shareholder developments. The company, a key player in its industry, has disclosed essential updates about the share capital and voting rights held by Park Street Asset Management Ltd., a trusted partner in managing its shareholding. Capital Reduction and...

Continue Reading
Alamos Gold's Robust Quarterly Dividend and Strategic Buybacks

Updated Category News Views 150

Quarterly Dividend Announcement by Alamos Gold All figures mentioned are in United States dollars unless specified otherwise. In a recent announcement, Alamos Gold Inc. (TSX:AGI; NYSE:AGI) has revealed a significant update regarding its shareholder value strategies. The Company’s Board of Directors has declared a quarterly dividend of US$0.025 per common share. This...

Continue Reading
AITX Expands Innovative Logistics Solutions with ROAMEO

Updated Category News Views 98

Revolutionizing Logistics with AITX and ROAMEO In an ever-changing world of logistics, AITX’s Robotic Assistance Devices, Inc. (RAD) is stepping up to the plate with new solutions that elevate operational efficiency and security standards. The company has honed its focus on creating tailored solutions for the logistics sector, which is widely acknowledged for its...

Continue Reading
BlackRock's Bold Bet on Bitcoin Amid Microsoft's Hesitation

Updated Category News Views 131

BlackRock's Investment Insights Into Bitcoin Microsoft Corp. (NASDAQ: MSFT) recently made headlines when it decided against exploring Bitcoin as a potential investment. Despite this, its significant shareholder, BlackRock, is making waves with its strong backing for the leading cryptocurrency. Known for its strategic investments, BlackRock's optimism presents a stark...

Continue Reading